Objective: Menopausal hot flashes can seriously disrupt the lives of symptomatic women. The physiological mechanisms of the hot flash efferent responses, particularly in the cutaneous circulation, are not completely understood. The aim of this study was to examine the mechanisms of increases in skin blood flow during the postmenopausal hot flash in symptomatic women.
H ot flashes (or flushes) are a primary symptom of menopause that can seriously disrupt the lives of symptomatic women. 1 Approximately 70% of women experience hot flashes for 1 to 5 years after the onset of the menopausal transition. [1] [2] [3] [4] The incidence and severity of symptoms are even higher in surgically induced postmenopausal women and oncological female patients. 2, 5, 6 Hot flashes are typically defined as sudden subjective sensations of heat, frequently accompanied by skin flushing and perspiration. 1, 4, 7, 8 Symptomatic women also report a range of additional symptoms during a hot flash, such as anxiety, frustration, embar-rassment, nausea, and depression. 1, [8] [9] [10] Importantly, hot flashes can negatively affect concentration, sleep quality, and sexual function and result in fatigue and stress, 1, [11] [12] [13] [14] thereby significantly reducing the quality of life and overall health of affected women. 3, 13, 15, 16 The physiological mechanisms associated with hot flashes, particularly in the cutaneous circulation, are not completely understood. We recently showed large increases in sternum and forearm skin blood flow during hot flashes in symptomatic postmenopausal women, 17, 18 confirming earlier speculations that skin blood flow increases during hot flashes. [19] [20] [21] [22] Such increases in the blood flow of nonglabrous skin (ie, hairy skin) could be achieved through the withdrawal of sympathetic vasoconstrictor activity, through the engagement of a separate sympathetic cholinergic active vasodilator system 23 and/or through nonneural circulating factors, as previously proposed. 20, 24 We hypothesized that increases in skin blood flow during postmenopausal hot flashes are neurally mediated predominantly through the engagement of sympathetic cholinergic active vasodilation recognized to occur in human skin. 23 The aim of this study was, therefore, to examine the mechanisms responsible for increases in skin blood flow during the postmenopausal hot flash. This aim was achieved by recording skin blood flow responses during hot flashes at forearm and glabellar sites locally pretreated with botulinum toxin A (BTX) to block the release of neurotransmitters from sympathetic cholinergic nerves and by recording postganglionic skin sympathetic neural activity (SSNA) in symptomatic postmenopausal women.
METHODS

Participants
Nineteen postmenopausal women participated in three separate but similar protocols. Not all women participated in each protocol. Their mean T SD age and body mass index were 50 T 5 years (range, 41-60 y) and 27 T 6 kg/m 2 (range, 21-42 kg/m 2 ), respectively. All participants had been amenorrheic for at least 12 months and were experiencing at least four hot flashes a day (verified by a 7-d hot flash frequency journal completed before the study). 12 Participants were healthy and free of cardiovascular and metabolic diseases and were not taking hormone therapy or any other treatments to alleviate hot flash symptoms. Participants refrained from alcohol and exercise 24 hours and from caffeine 12 hours before the study. Written informed consent forms were obtained from all participants before they enrolled in the study. Procedures and consent forms were approved by the University of Texas Southwestern Medical Center at Dallas and Texas Health Presbyterian Hospital Dallas and were in agreement with the principles set by the Declaration of Helsinki.
Experimental design
Experiments were performed in a temperature-controlled laboratory (26 T 1-C) in the morning or early afternoon at least 2 hours postprandial. For protocols 1 and 2, at least 3 days before experimentation, participants received an intradermal injection of BTX (10 units in 0.15 mL normal saline) to locally abolish sympathetic cholinergic neural transmission previously shown to be responsible for heat stressYinduced cutaneous vasodilation. [25] [26] [27] This dose and time frame were used to be consistent with previous studies from our laboratory and others that used the same procedures and showed a consistent and clear BTX blockade of hyperthermia-induced increases in skin blood flow. [25] [26] [27] BTX was injected in the forearm in protocol 1 (eight participants) and in the glabellar region of the forehead in protocol 2 (four participants). Protocol 2 was conducted to confirm the findings of protocol 1 but from an area of the body where hot flash symptoms are particularly prominent in symptomatic women. 12 In protocol 3 (10 participants), multifiber recordings of SSNA were obtained from participants during hot flashes to provide additional insight/confirmation regarding a neural origin of observations from protocols 1 and 2.
For all protocols, participants rested in the semirecumbent position for È90 minutes while waiting for a hot flash to occur. The onset of a hot flash was objectively identified as a transient and pronounced increase in sweat rate. 18, 28, 29 During this period, 34-C water was perfused through the tube-lined suit. Participants were then exposed to a mild heat stress by perfusing 43 to 48-C water through the suit for È60 minutes. This mild heating was used to provoke hot flashes 1, 28 and to verify the effectiveness of the BTX, which was confirmed by an absence of substantial cutaneous vasodilation at the BTX-treated site, relative to the adjacent control site, upon an increase of at least 0.4-C in the participant's internal temperature. [25] [26] [27] 
Instrumentation and measurements
Participants were placed in a tube-lined suit (jacket and/or pants; Med-Eng, Ottawa, Canada) that permitted the control of skin temperature by changing the temperature of the water perfusing the suit. In protocols 1 and 3, the tube-lined suit did not cover the forearm that received the BTX injection or the lower limb from which SSNA was obtained, respectively. Heart rate was obtained from an electrocardiograph (SpaceLabs, Redmond, WA) interfaced with a cardiotachometer (CWE, Ardmore, PA). Continuous beat-by-beat arterial blood pressure was recorded from a finger (Finometer, FMS, Amsterdam, The Netherlands). Intermittent arterial blood pressure was also measured from the brachial artery by electrosphygmomanometry (SunTech, Raleigh, NC). Mean skin temperature was measured via the electrical average of six thermocouples attached to the skin. 30 Core temperature was measured from an ingestible pill telemetry system (HTI Technologies, Palmetto, FL) that was swallowed at least 2 hours before data collection began. Cutaneous blood flow was indexed using multifiber laser-Doppler flowmetry probes (Perimed, North Royalton, OH). For protocols 1 and 2, laser-Doppler flow probes were placed over each injection site and over adjacent untreated areas (ie, control sites) that did not receive BTX. Sweat rate was continuously recorded using the ventilated capsule technique coupled with capacitance hygrometry (Viasala, Woburn, MA) or was indexed using galvanic skin conductance (Biopac System, Santa Barbara CA). Participants also indicated their subjective onset and offset of a hot flash by manually triggering a switch.
For protocol 3, multifiber recordings of SSNA were obtained using a tungsten microelectrode positioned in the common peroneal nerve. A reference electrode was placed subcutaneously È2 to 3 cm from the recording electrode. The position of the recording electrode was adjusted until a site was attained in which bursts of SSNA were identified using previously established criteria. 31, 32 Nerve signals were amplified, passed through a bandpass filter with a bandwidth of 700 to 2,000 Hz, integrated with a time constant of 0.1 second (Iowa Bioengineering, Iowa City, IA), and were routed to an oscilloscope and a loudspeaker for monitoring throughout the study. Sweat rate was continuously recorded using capacitance hygrometry, together with skin blood flow, within the region of innervation of the recorded nerve (ie, primarily dorsal foot).
Data analysis
Data were sampled at 50 Hz in protocols 1 and 2 and at 200 Hz in protocol 3 via a data-acquisition system (Biopac System). Because of the variance in the length of hot flashes, each hot flash was divided into eight equal segments, with each segment representing 12.5% of hot flash duration. Fivesecond periods of data at the end of each segment and over a period of 2 minutes before and up to 5 minutes after the hot flash were used in the statistical analysis. Cutaneous vascular conductance was calculated from the ratio of skin blood flow to arterial blood pressure. Cutaneous vascular responses were expressed as percent increase in cutaneous vascular conductance from preYhot flash baseline. Thirty seconds of SSNA data were analyzed during the following time points: 2 to 3 minutes before a hot flash (eg, nonYhot flash), the peak of SSNA during the hot flash, and 2 to 3 minutes after the hot flash (eg, postYhot flash). SSNA was normalized relative to the preYhot flash period, with the mean SSNA of that period being assigned a value of 100 and subsequent changes expressed relative to that normalized baseline value.
Differences in cutaneous vascular conductance at the control and BTX sites before, during, and after the hot flash were evaluated using a repeated-measures two-way analysis of variance (ANOVA) with main effects of time and site. Thermoregulatory, hemodynamic, and SSNA responses before, during, and after the hot flash were evaluated using a repeated-measures one-way ANOVA (main effect of time). Differences in steadystate thermoregulatory and hemodynamic responses, as well as the skin blood flow responses at the control and BTX-treated sites, between normothermia and at the end of the mild heat stress were assessed using paired t tests or a repeated-measures two-way ANOVA (main effects of time and site), where appropriate. All values are reported as mean T SD unless indicated. P G 0.05 was considered statistically significant.*
RESULTS
Hot flash responses Protocol 1
Eighteen hot flashes were recorded during the experimental sessions for protocol 1, with an average duration of 3.2 T 1.6 minutes (range, 1.5-7.4 min). Sternal and forearm sweat rate increased at the onset of each hot flash and then returned to baseline by the end of the flash (both P G 0.001; Fig. 1 ). Before the hot flashes, skin blood flow, as indicated by cutaneous vascular conductance, was similar between the control and BTX-treated sites (0.55 T 0.31 vs 0.59 T 0.35 arbitrary perfusion units [AU]/mm Hg, respectively; P = 0.59). Relative to the nonYhot flash state, forearm cutaneous vascular conductance at the untreated sites significantly increased È45 seconds before and throughout the first half of the hot flash (P G 0.001; Fig. 2 ). In contrast, although cutaneous vascular conductance at the BTX sites also increased during the hot flash (P G 0.05), this increase was greatly attenuated relative to the untreated sites (P G 0.001 for interaction effect of site and time; Fig. 2 ). No detectable change in core temperature was identified during the 2-minute period before the hot flash or throughout the hot flash; thereafter, core temperature slightly decreased 1 to 2 minutes after the hot flash period (j0.04 T 0.10-C; P G 0.05). Mean skin temperature slightly increased during the initial stages of the hot flash (0.07 T 0.09-C; P G 0.05). Mean arterial blood pressure decreased during the hot flashes (9 T 9 mm Hg; P G 0.05), whereas heart rate increased (11 T 7 beats/min j1 ; P G 0.05).
Protocol 2
Eight hot flashes were recorded during the experimental sessions of protocol 2 (duration, 3.7 T 1.7 min; range, 1.8-6.4 min). Glabellar skin blood flow, indicated by cutaneous vascular conductance, was not different before the hot flashes between the control and BTX sites (0.93 T 0.60 vs 0.84 T 0.24 AU mm Hg j1 , respectively; P = 0.70). Similar to the forearm data of protocol 1, glabellar skin blood flow and cutaneous vascular conductance at the control sites increased just before and during the hot flash (P G 0.001). Although subtle increases in these variables occurred at the BTX site during the hot flash (P G 0.05), they were largely blocked by BTX treatment (P G 0.01 for interaction effect of site and time; Fig. 3 ). Other thermal and hemodynamic responses were similar to those observed in protocol 1.
Mild heating after both protocols 1 and 2 caused expected increases of È3-C and È0.5-C in mean skin and core temperatures, respectively (Table 1 ). This level of heating significantly increased skin blood flow and cutaneous vascular conductance from the untreated sites (P G 0.01), whereas neither skin blood flow nor cutaneous vascular conductance changed at the BTXtreated sites (P 9 0.50; P G 0.01 for the interaction effect of time and site), thereby confirming the effectiveness of the BTX treatment. 23 
Protocol 3
Seventeen hot flashes were recorded during the experimental sessions of protocol 3. SSNA increased by approximately fourfold during these hot flashes (from 100 normalized units to 411 T 183 normalized units; P G 0.001; Figs. 4 and 5) and returned to baseline values after the hot flash (110 T 52 normalized units; P = 0.99 relative to preYhot flash baseline). Increases in SSNA were accompanied by increases in sweat rate (from 0.11 T 0.05 to 0.16 T 0.05 mg.cm j2 .min j1 ; P G 0.05) and cutaneous vascular conductance (from 0.22 T 0.13 to 0.44 T 0.36 AU mm Hg j1 ; P G 0.05) within the area of innervation of the recorded nerve.
DISCUSSION
The aim of this study was to examine the possible mechanisms responsible for the increases in skin blood flow during the postmenopausal hot flash. To achieve this aim, skin blood flow at sites with and without pretreatment of BTX, along with SSNA, were evaluated before, during, and after hot flashes in symptomatic women. The primary findings are that increases in skin blood flow and cutaneous vascular conductance during a hot flash are blocked or substantially inhibited by BTX, evident in both the forearm and glabellar regions. Furthermore, sympathetic neural activity to the skin signif-icantly increases during, and returns to baseline after, the hot flashes. These data demonstrate that the increase in skin blood flow during the postmenopausal hot flash is predominantly a neurally mediated event and is thus unlikely to be caused by nonneural mechanisms as previously suggested. 20 Despite the clear disruption that hot flashes cause to postmenopausal women's lives, the physiological mechanisms of a hot flash are not completely understood, particularly with regard to changes in skin blood flow. In the present study, skin blood flow increased by approximately twofold at the forearm and glabellar regions during the hot flash, in agreement with prior data from our laboratory. 17, 18 The mechanism(s) responsible for these increases in skin blood flow is previously unknown, although we have recently shown that nitric oxide is probably involved. 17 Increases in skin blood flow from nonglabrous skin during a hot flash could be achieved through the withdrawal of sympathetic vasoconstrictor activity, increases in sympathetic cholinergic vasodilator activity, a combination of both neural mechanisms, 23, 33 and/or nonneural factors 35 as previously proposed. 20 In the present study, intradermal injections of BTX were used to locally block the release of neurotransmitters from nerves responsible for cutaneous active vasodilation via sympathetic cholinergic nerves. [25] [26] [27] 35 The effectiveness of the blockade was confirmed via a lack of cutaneous vasodilation at these sites in response to whole-body heating ( Table 1 ). The increase in cutaneous vascular conductance during the hot flashes at untreated sites, coupled with little to no changes in cutaneous vascular conductance at the BTX sites, strongly suggests that increases in skin blood flow during hot flashes are predominantly neurally mediated via sympathetic cholinergic nerves.
Robust increases in SSNA during the hot flash further support the conclusion that cutaneous vasodilation during the hot flash is neurally mediated. The integrated SSNA signal is a composite of cutaneous vasoconstrictor, sudomotor, and vasodilator neural activities, with the relative contribution dependent predominantly on the thermal status of the individual. [36] [37] [38] An increase in SSNA could therefore be a result of an increase in one, or a combination, of these neural components. Given the observed increases in skin blood flow and sweating within the region innervated by the recorded nerve in the present study, it is probable that the recorded neural signal contains sudomotor and cutaneous vasodilator neural activities, but probably not cutaneous vasoconstrictor neural activities. Within this context, it is important to emphasize that similar increases in SSNA are observed during whole-body heat stress that also increases cutaneous vascular conductance and sweating. 36, 39 In contrast to the findings of the present study, the results of Freedman et al 20 show that increases in blood flow during hot flashes persisted from a finger that received neural blockade via local lidocaine injection. These findings led to the suggestion that digit vasodilation during a hot flash may be due to circulating vasodilating substances (eg, a nonneural mechanism). However, there is a key difference in the methodological approaches of that work and of the present study. Neural control of skin blood flow over most of the skin's surface (ie, nonglabrous hairy skin) is regulated by both a vasoconstrictor and an active vasodilator neural system, which is in contrast to glabrous skin of the finger, which is controlled solely by a vasoconstrictor limb. 40 Therefore, the mechanisms responsible for increases in blood flow over most of the body's skin surface during a hot flash may be different relative to the finger and, as such, should not be assumed to be interchangeable. Despite the use of BTX, subtle but significant increases in cutaneous vascular conductance were evident at both the forearm and forehead BTX sites. Such an observation raises the possibility that a component, albeit relatively minor, of the increase in skin blood flow during a hot flash occurs through withdrawal of sympathetic vasoconstrictor activity and/or nonneural factors. 20, 24 Limitations to the interpretation of the findings Participants were not aware of the precise rationale for the use of BTX, although it is improbable that they were naive as to the use of BTX for cosmetic purposes. Regardless, it is very improbable that, even if participants were aware of the mechanisms of BTX, this would have affected the interpretation of the data given the clear divergence of responses between the control and BTX sites.
Protocol 2 was conducted to confirm the findings of protocol 1 from an area often associated with hot flash symptoms (glabellar region). We recognize, however, that the small number of participants is a limitation, given the possibility of a type I error. Nevertheless, because the differences in skin blood flow responses between the BTX and the control sites were so pronounced, coupled with similar findings from the forearm in protocol 1, we are quite confident with the presented interpretation of the data despite the small number of participants in protocol 2.
The authors are not contending that, based upon the presented findings, BTX treatment would be of benefit to alleviate symptoms associated with hot flashes. BTX was administered solely for the purpose of identifying mechanisms responsible for cutaneous vascular responses during hot flashes.
CONCLUSIONS
The findings of this study show that increases in sympathetic nerve activity to the skin occur along with increases in skin blood flow, cutaneous vascular conductance, and sweating during a hot flash. Furthermore, the increases in cutaneous blood flow were substantially inhibited at the forearm and glabellar sites locally pretreated with BTX. These findings strongly indicate that increases in skin blood flow during the postmenopausal hot flash are neurally mediated via the same, or related, mechanisms as cutaneous vasodilation and sweating necessary for thermoregulation in heat-stressed individuals. [25] [26] [27] 
